Skip to main content
Signal8

SHARMA PANNA

SEC insider (Form 3/4/5 filer). CIK 0001157989. President & CEO at Lantern Pharma Inc. (LTRN). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2020. Located in DALLAS, TX.

Companies SHARMA PANNA has filed insider reports for

  • Lantern Pharma Inc. (LTRN): Director, Officer, President & CEO
SHARMA PANNA profile photo

SHARMA PANNA

CIK: 0001157989

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Lantern Pharma Inc. logo
LTRN

Lantern Pharma Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Lantern Pharma Inc. logo
    LTRN

    Lantern Pharma Inc.

    Jun 15, 2020
    Disposition

    Stock Option (Right to Buy)

    Direct
    76.6K shares-
  • Lantern Pharma Inc. logo
    LTRN

    Lantern Pharma Inc.

    Jun 15, 2020
    Award

    Stock Option (Right to Buy)

    Direct
    76.6K shares-

1-2 of 2